2024 SPEAKERS | Kisaco Research

2024 SPEAKERS

Advanced Wound Care USA
16-17 April, 2024
Boston, USA

2024 SPEAKERS

Introducing our pioneering 2024 speaker faculty.

  • Author:

    Kevin Richardson

    Chief Strategic Officer
    SANUWAVE

    Kevin Richardson

    Chief Strategic Officer
    SANUWAVE
  • Author:

    Julie Morabito

    Assistant Director
    FDA

    Assistant Director, Division of Infection Control and Plastic and Reconstructive Surgery at FDA’s Center for Devices and Radiological Health (CDRH). (Plastic Surgery Skin and Wound Devices Team).

    Julie Morabito

    Assistant Director
    FDA

    Assistant Director, Division of Infection Control and Plastic and Reconstructive Surgery at FDA’s Center for Devices and Radiological Health (CDRH). (Plastic Surgery Skin and Wound Devices Team).

  • Author:

    Jaideep Banerjee

    Lead Medical Science Liaisons and Clinical Strategy
    Smith & Nephew

    Jaideep Banerjee

    Lead Medical Science Liaisons and Clinical Strategy
    Smith & Nephew
  • Author:

    Laurent Decory

    COO
    Aurealis Therapeutics

    Laurent Decory

    COO
    Aurealis Therapeutics
  • Author:

    Artem Trotsyuk

    Venture Partner
    LongeVC

    Artem Trotsyuk

    Venture Partner
    LongeVC
  • Author:

    Ira Herman

    Co-Founder
    Precision Healing

    Ira Herman

    Co-Founder
    Precision Healing
  • Author:

    Kent Nielsen

    Principal Scientist, New Business Development
    Molnlycke

    Kent Nielsen

    Principal Scientist, New Business Development
    Molnlycke
  • Author:

    Thomas Serena

    Founder & CEO
    SerenaGroup

    Dr. Thomas E. Serena MD FACS FACHM MAPWCA, Founder and Medical Director of The SerenaGroup®, a family of wound, hyperbaric and research companies, is a Phi Beta Kappa graduate of The College of William and Mary and Penn State Medical School.

    To date he has opened and operates wound care centers across the United Sates and globally. Dr. Serena has been the lead or Principal investigator in over 100 clinical trials, including gene therapy for critical limb ischemia, antimicrobial dressings, growth factors, topical and parenteral antibiotics and CTP therapy. He founded the first wound healing cooperative research group that produced more than 12 manuscripts in 2016 alone. In 2011 he developed a diagnostic technique that now bears his name (The Serena Technique©). He holds numerous patents on wound care devices and dressings.

    He is recognized internationally as an expert in the field of wound healing: He has more than 200 published papers and has given more than 1000 invited lectures throughout the world. He has published three medical textbooks and authored numerous book chapters. He has been a member of the Board of Directors of the Wound Healing Society and served two terms on the board of the Association for the Advancement of Wound Care (AAWC) and is now the President-Elect. He has also been Vice-President of the American College of Hyperbaric Medicine and President of the American Professional Wound Care Association.

    Dr. Serena has done extensive medical relief work with Health Volunteers Overseas and served as chairman of the AAWC Global Volunteers/HVO Steering Committee until 2016. In 2016 in partnership with HEAL Foundation he opened a wound clinic in Ho Chi Minh, Vietnam. Outside of wound healing, he consulted for the government of Rwanda on AIDS prevention research.

    Thomas Serena

    Founder & CEO
    SerenaGroup

    Dr. Thomas E. Serena MD FACS FACHM MAPWCA, Founder and Medical Director of The SerenaGroup®, a family of wound, hyperbaric and research companies, is a Phi Beta Kappa graduate of The College of William and Mary and Penn State Medical School.

    To date he has opened and operates wound care centers across the United Sates and globally. Dr. Serena has been the lead or Principal investigator in over 100 clinical trials, including gene therapy for critical limb ischemia, antimicrobial dressings, growth factors, topical and parenteral antibiotics and CTP therapy. He founded the first wound healing cooperative research group that produced more than 12 manuscripts in 2016 alone. In 2011 he developed a diagnostic technique that now bears his name (The Serena Technique©). He holds numerous patents on wound care devices and dressings.

    He is recognized internationally as an expert in the field of wound healing: He has more than 200 published papers and has given more than 1000 invited lectures throughout the world. He has published three medical textbooks and authored numerous book chapters. He has been a member of the Board of Directors of the Wound Healing Society and served two terms on the board of the Association for the Advancement of Wound Care (AAWC) and is now the President-Elect. He has also been Vice-President of the American College of Hyperbaric Medicine and President of the American Professional Wound Care Association.

    Dr. Serena has done extensive medical relief work with Health Volunteers Overseas and served as chairman of the AAWC Global Volunteers/HVO Steering Committee until 2016. In 2016 in partnership with HEAL Foundation he opened a wound clinic in Ho Chi Minh, Vietnam. Outside of wound healing, he consulted for the government of Rwanda on AIDS prevention research.

  • Author:

    Amay Bandodkar

    Assistant Professor
    North Carolina State University

    Amay Bandodkar

    Assistant Professor
    North Carolina State University
  • Author:

    Jens Kirsch

    CEO
    Terraplasma Medical

    Jens Kirsch

    CEO
    Terraplasma Medical
  • Author:

    Ankit Agarwal

    CEO
    Imbed Biosciences

    Ankit Agarwal

    CEO
    Imbed Biosciences
  • Author:

    Jon Bloom

    CEO
    Podimetrics

    Jon Bloom

    CEO
    Podimetrics
  • Author:

    Dan Holsworth

    CEO
    Eluciderm

    Dan Holsworth

    CEO
    Eluciderm
  • Author:

    Jason Hanft

    CEO & Founder
    Defender

    Jason Hanft

    CEO & Founder
    Defender
  • Author:

    Emma Wright

    CMO
    Mölnlycke

    Emma is an industry professional with 25 years of experience in medical devices in both start-up and international companies, based in UK, US and most recently in Sweden.  Her career has been focused on the development and commercialisation of devices in wound care, reconstructive surgery and orthopedics with a specific interest in products that actively promote tissue repair.  In the last 10 years Emma has led clinical, medical and health economic teams with responsibility for clinical evidence generation, professional education, medical affairs and health economics. 

    Emma Wright

    CMO
    Mölnlycke

    Emma is an industry professional with 25 years of experience in medical devices in both start-up and international companies, based in UK, US and most recently in Sweden.  Her career has been focused on the development and commercialisation of devices in wound care, reconstructive surgery and orthopedics with a specific interest in products that actively promote tissue repair.  In the last 10 years Emma has led clinical, medical and health economic teams with responsibility for clinical evidence generation, professional education, medical affairs and health economics. 

  • Author:

    Ibraheem Badejo

    Senior R&D Director, External Front End Innovation
    Johnson & Johnson

    Ibraheem (Ib) is Senior R&D Director, External Front End Innovation at Johnson & Johnson Innovation, Boston. He leverages his expertise in smart materials and biomaterials to support the medical device sector.

    From 2010 to 2013, Ib was a Research Fellow at Global Surgery Group of Johnson & Johnson, where he was responsible for external and front-end innovations and intellectual property for Ethicon Biosurgery. From 2006 to 2010, he was the Director of Applied Research & New Technology Assessment of novel biomaterials. Prior to that, he was the Chief Scientist of Closure Medical Corp (acquired by J&J in 2005). Prior to joining Closure, he held various positions at Bayer, North Carolina State University, College of Charleston. He currently serves as an Adjunct Professor of Biomedical Engineering at Drexel University.

    During his career, Ib has led teams in the development of commercialized biomaterials based products and new technology / products licensed or acquired.

    Ib received his BA degree in chemistry from Avila University.  He received his PhD in Organic chemistry from the University of Toledo, where he was the Robert Whiteford Memorial Scholar for Outstanding Graduate Research and a Petroleum Research Fund Fellow. He is also the recipient of 24 US patents with others pending

    Ibraheem Badejo

    Senior R&D Director, External Front End Innovation
    Johnson & Johnson

    Ibraheem (Ib) is Senior R&D Director, External Front End Innovation at Johnson & Johnson Innovation, Boston. He leverages his expertise in smart materials and biomaterials to support the medical device sector.

    From 2010 to 2013, Ib was a Research Fellow at Global Surgery Group of Johnson & Johnson, where he was responsible for external and front-end innovations and intellectual property for Ethicon Biosurgery. From 2006 to 2010, he was the Director of Applied Research & New Technology Assessment of novel biomaterials. Prior to that, he was the Chief Scientist of Closure Medical Corp (acquired by J&J in 2005). Prior to joining Closure, he held various positions at Bayer, North Carolina State University, College of Charleston. He currently serves as an Adjunct Professor of Biomedical Engineering at Drexel University.

    During his career, Ib has led teams in the development of commercialized biomaterials based products and new technology / products licensed or acquired.

    Ib received his BA degree in chemistry from Avila University.  He received his PhD in Organic chemistry from the University of Toledo, where he was the Robert Whiteford Memorial Scholar for Outstanding Graduate Research and a Petroleum Research Fund Fellow. He is also the recipient of 24 US patents with others pending

  • Author:

    Monique Rennie

    Global Director, Medical Affairs
    Mölnlycke

    Monique Rennie

    Global Director, Medical Affairs
    Mölnlycke
  • Author:

    Micaela Gray

    Medical Affairs Manager
    Moleculight

    Micaela Gray

    Medical Affairs Manager
    Moleculight
  • Author:

    Caroline Fife

    CMO
    Intellicure

    Caroline Fife

    CMO
    Intellicure
  • Author:

    Carolina Wuesthoff

    Global Manager Medical Engagement & Communications
    Moleculight

    Carolina Wuesthoff

    Global Manager Medical Engagement & Communications
    Moleculight
  • Author:

    Kris Kieswetter

    Senior Director, Research and Technology
    3M

    Kris Kieswetter

    Senior Director, Research and Technology
    3M

SUBMIT A SPEAKER

As the Advanced Wound Care Summit Series expands, we are keen to hear your feedback on whom you want to hear from within the industry.

If you have a speaker or content idea that you would like to suggest for our 2024 USA Summit please submit your suggestions below.

All applications will be reviewed and our team will be in touch if we have any further questions.

SUBMIT SUGGESTION